发明名称 Herpesvirusspesifiset immunologiset aineet ja menetelmät
摘要 Disclosed are antibody substances displaying unique, multi-specific immunoreactivities with respect to glycoprotein D of Herpes Simplex Virus types 1 and 2 (HSV gD-1 and gD-2) and structurally related compounds. Illustratively, an IgG Type 2 monoclonal antibody material produced by mouse-mouse hybridoma cell line A.T.C.C. No. HB8606 is capable of in vitro neutralization of HSV-1 and HSV-2 infectivity and of specific immunological reactivity and reversible immunobinding with natrually-occuring and recombinant gD-1 and gD-2 in both native and denatured conformations as well as with proteinaceous materials (produced, e.g., by proteolytic digestion of naturally-occurring materials, by recombinant methods, or by polymerization of amino acids) which comprise a primary structural conformation substantially duplicating part or all of that which is predicted to be extant at residues 266 through 287 of gD-1 and gD-2 [i.e., PELA(or V)PEDPEDSALLEDPV(or A)GTVA(or S)]. Disclosed also are novel procedures for detection, quantification and isolation by affinity purification of gD-1, gD-2 and structurally related compounds.
申请公布号 FI102838(B1) 申请公布日期 1999.02.26
申请号 FI19860001708 申请日期 1986.04.23
申请人 UNIVERSITY PATENTS, INC. 发明人 COHEN, GARY H.;EISENBERG, ROSELYN J.
分类号 A61K39/245;A61K39/395;A61P31/12;B43L1/04;C07K1/16;C07K1/22;C07K14/00;C07K14/005;C07K14/03;C07K14/035;C07K14/195;C07K16/00;C07K16/08;C07K19/00;C12N5/00;C12N5/10;C12N5/12;C12N15/00;C12N15/02;C12P21/00;C12P21/08;C12R1/91;G01N33/53;G01N33/569;G01N33/571;G01N33/577;(IPC1-7):C07K16/08;C07K5/18;C07K33/53;C07K33/571 主分类号 A61K39/245
代理机构 代理人
主权项
地址